IL15 and congenital rubella syndrome: Armored CAR NKs encoding IL-15 have shown remarkable in vivo persistence, with some patients maintaining NK cells for over a year, accompanied by robust antitumor activity but without CRS, neurotoxicity, or GvHD [39,138].